AG-1024 Sensitizes Sorafenib-Resistant Hepatocellular Carcinoma Cells to Sorafenib via Enhancing G1/S Arrest

PURPOSE: The frequency in resistance to sorafenib accounts for the grim prognosis of advanced hepatocellular carcinoma (HCC). In the present study, we explore the anti-cancer efficacy of co-administration of sub-toxic AG-1024 with sorafenib in HCC cells to enhance the sensitivity of these cells to s...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Onco Targets Ther
Huvudupphovsmän: Zhou, Wei, Lou, Weiyang, Chen, Junru, Ding, Bisha, Chen, Binjie, Xie, Haiyang, Zhou, Lin, Zheng, Shusen, Jiang, Donghai
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove 2021
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7894871/
https://ncbi.nlm.nih.gov/pubmed/33623392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S289324
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk